Literature DB >> 3838153

Quantitation and characterization of human plasma neurotensin-like immunoreactivity in response to a meal.

Y C Lee, J M Allen, L O Uttenthal, P M Roberts, S S Gill, S R Bloom.   

Abstract

The secretion and metabolism of endogeneous neurotensin-like immunoreactivities after a test meal were studied in five healthy human subjects. Intact neurotensin and the N-terminal metabolic fragment, neurotensin 1-8, were quantified by radioimmunoassay with C- and N-terminally directed antisera in conjunction with gel filtration of plasma samples obtained at timed intervals. Both C- and N-terminal neurotensin-like immunoreactivities rose after the meal, reaching a plateau level after 20 and 30 min, respectively. During the plateau phase, which lasted for the rest of the experimental period of 180 min, the molar ratio of intact neurotensin to neurotensin 1-8 remained approximately constant at 1:4.6. Meal-stimulated immunoreactive neurotensin appeared to be metabolized in a manner comparable to that of exogenously infused neurotensin in man. The results suggest that intact neurotensin is secreted at an approximately constant rate during the plateau phase. The relatively low plateau level of neurotensin 1-8, which has a much longer half-life than intact neurotensin in the circulation, implies that only a fraction of the secreted intact neurotensin is metabolized to neurotensin 1-8, indicating the existence of alternative pathways of neurotensin metabolism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3838153     DOI: 10.1007/bf01308198

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry.

Authors:  J M Polak; S N Sullivan; S R Bloom; A M Buchan; P Facer; M R Brown; A G Pearse
Journal:  Nature       Date:  1977-11-10       Impact factor: 49.962

2.  Characterization of human plasma neurotensin-like immunoreactivity after fat ingestion.

Authors:  E Theodorsson-Norheim; S Rosell
Journal:  Regul Pept       Date:  1983-07

3.  Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel.

Authors:  G L Ferri; T E Adrian; M A Ghatei; D J O'Shaughnessy; L Probert; Y C Lee; A M Buchan; J M Polak; S R Bloom
Journal:  Gastroenterology       Date:  1983-04       Impact factor: 22.682

4.  Cation-sensitive neutral endopeptidase: isolation and specificity of the bovine pituitary enzyme.

Authors:  S Wilk; M Orlowski
Journal:  J Neurochem       Date:  1980-11       Impact factor: 5.372

5.  The effect of food ingestion on circulating neurotensin-like immunoreactivity (NTLI) in the human.

Authors:  M L Mashford; G Nilsson; A Rökaeus; S Rosell
Journal:  Acta Physiol Scand       Date:  1978-10

6.  Effect of neurotensin on pancreatic function in man.

Authors:  D R Fletcher; A M Blackburn; T E Adrian; V S Chadwick; S R Bloom
Journal:  Life Sci       Date:  1981-11-23       Impact factor: 5.037

7.  Immunohistochemical localization of neurotensin in endocrine cells of the gut.

Authors:  F Sundler; R Håkanson; R A Hammer; J Alumets; R Carraway; S E Leeman; E A Zimmerman
Journal:  Cell Tissue Res       Date:  1977-03-16       Impact factor: 5.249

8.  A radioimmunoassay for neurotensin in human plasma.

Authors:  A M Blackburn; S R Bloom
Journal:  J Endocrinol       Date:  1979-11       Impact factor: 4.286

9.  The effect of ingestion of amino acids, glucose and fat on circulating neurotensin-like immunoreactivity (NTLI) in man.

Authors:  S Rosell; A Rökaeus
Journal:  Acta Physiol Scand       Date:  1979-11

10.  Evidence that (Glu4)-neurotensin is the naturally occurring neurotensin in plasma.

Authors:  E Theodorsson-Norheim
Journal:  Peptides       Date:  1983 Jul-Aug       Impact factor: 3.750

View more
  10 in total

1.  Time course of adaptive regulatory peptide changes following massive small bowel resection in the dog.

Authors:  T E Adrian; J S Thompson; E M Quigley
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Gut regulatory peptides and intestinal permeability in acute infantile gastroenteritis.

Authors:  G R Lawson; R Nelson; M F Laker; M A Ghatei; S R Bloom; A Aynsley-Green
Journal:  Arch Dis Child       Date:  1992-03       Impact factor: 3.791

3.  Inhibitory effect of neurotensin on gastric acid secretion in rats. Development of a bioassay model.

Authors:  R A Hammer; R E Hernandez; A Shepard
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

4.  Effects of jejunoileal autotransplantation on gastrointestinal regulatory peptides.

Authors:  T E Adrian; E M Quigley; S G Rose; T J Johnson; J S Thompson
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

5.  Effect of meal composition and sham feeding on duodenojejunal motility in humans.

Authors:  E E Soffer; T E Adrian
Journal:  Dig Dis Sci       Date:  1992-07       Impact factor: 3.199

6.  Responses of python gastrointestinal regulatory peptides to feeding.

Authors:  S M Secor; D Fehsenfeld; J Diamond; T E Adrian
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

7.  Effect of renal failure or portacaval shunt on release of neurotensin in man.

Authors:  E R Eaves; J Hansky
Journal:  Dig Dis Sci       Date:  1987-01       Impact factor: 3.199

8.  Regulation of gastric acid secretion by neurotensin in man. Evidence against a hormonal role.

Authors:  M H Mogard; V Maxwell; B Sytnik; J H Walsh
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

9.  Effect of oral fat on plasma levels of neurotensin and neurotensin fragments in humans. Characterization by high-pressure liquid chromatography.

Authors:  E J Draviam; J R Upp; G H Greeley; C M Townsend; J C Thompson
Journal:  Dig Dis Sci       Date:  1990-02       Impact factor: 3.199

Review 10.  The Role of Central Neurotensin in Regulating Feeding and Body Weight.

Authors:  Jariel Ramirez-Virella; Gina M Leinninger
Journal:  Endocrinology       Date:  2021-05-01       Impact factor: 4.736

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.